Cargando…
Systematical analysis of ferroptosis regulators and identification of GCLM as a tumor promotor and immunological biomarker in bladder cancer
Bladder cancer (BCa) is a life-threaten disease with an increasing incidence with age, and immunotherapy has become an important treatment for BCa, while the efficiency of the immune system declines with age. It is vital to reveal the mechanisms of tumor immune microenvironment (TIME) and identify n...
Autores principales: | Wang, Song, Wang, He, Zhu, Shaoxing, Li, Fangyin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638099/ https://www.ncbi.nlm.nih.gov/pubmed/36353567 http://dx.doi.org/10.3389/fonc.2022.1040892 |
Ejemplares similares
-
PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration
por: Wang, Song, et al.
Publicado: (2022) -
The Identification of Immunological Biomarkers in Kidney Cancers
por: Lopez-Beltran, Antonio, et al.
Publicado: (2018) -
Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer
por: Sun, Jiale, et al.
Publicado: (2021) -
Persistence of improved glucose homeostasis in Gclm null mice with age and cadmium treatment
por: Schaupp, Christopher M., et al.
Publicado: (2021) -
Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis
por: Kang, Yao, et al.
Publicado: (2021)